...
首页> 外文期刊>American Journal of Case Reports >Breast and Axillary Lymph Node Metastasis from Ovarian Cancer: A Case Report
【24h】

Breast and Axillary Lymph Node Metastasis from Ovarian Cancer: A Case Report

机译:来自卵巢癌的乳腺和腋窝淋巴结转移:案例报告

获取原文

摘要

Patient: Female, 70-year-old Final Diagnosis: Breast cancer ? ovarian cancer Symptoms: Anorexia ? dyspnea Medication: — Clinical Procedure: — Specialty: Oncology Objective: Rare disease Background: Breast metastasis (BM) is extremely rare. Ovarian cancer accounts for approximately 0.03% to 0.6% of all BMs. BM diagnosis is challenging and the prognosis very poor. The treatment is multidisciplinary and strictly related to multiple clinical and biological factors. Case Report: A 70-year-old non-smoking Caucasian woman was hospitalized for a 4-month history of abdominal pain, anorexia, and weight loss of 10 kg. During the clinical examination, we found multiple axillary lymph nodes and a painless tumor lesion in the superior internal quadrant of the right breast. Whole body CT-scan and ~(18)F-fluorodeoxyglucose PET scan documented a right ovarian tumor associated with multiple metastases, a hyper-metabolic lesion of the right breast, and multiple axillary lymphadenopathies that were confirmed by breast ultrasonography. The percutaneous biopsy of both the right axillary lymph node and breast tumor showed a metastasis from a high-grade serous papillary ovarian adenocarcinoma. Considering the tumor aggressiveness and the lack of BRCA1 and BRCA2 mutations, we started systemic chemotherapy with a 3-week carboplatin/paclitaxel regimen combined with bevacizumab, which quickly improved the patient’s symptoms and induced a biological tumor response. Conclusions: This case reports a synchronous breast metastasis from an ovarian cancer and highlights this uncommon entity, which is very difficult to diagnose and treat. A differential diagnosis from a primary breast cancer should be considered as the treatment and prognosis of these 2 tumors are different.
机译:病人:女性,70岁的最终诊断:乳腺癌?卵巢癌症症状:厌食症吗?呼吸困难药物: - 临床手术: - 专业:肿瘤学目标:罕见疾病背景:乳腺转移(BM)极为罕见。卵巢癌占所有BMS的约0.03%至0.6%。 BM诊断具有挑战性,预后非常差。治疗是多学科,严格地与多种临床和生物因素有关。案例报告:70岁的禁烟白种人女子被住院治疗了4个月的腹痛,厌食症和10公斤体重减轻。在临床检查期间,我们发现了多个腋窝淋巴结和右乳房的高级内象限中的无痛肿瘤病变。全身CT-SCAN和〜(18)F-氟脱氧葡萄糖PET扫描记录了与多重转移相关的右卵巢肿瘤,右乳房的超代谢病变和通过乳房超声检查证实的多个腋窝淋巴结病。右腋窝淋巴结和乳腺肿瘤的经皮活检显示出来自高级浆液性乳头卵巢腺癌的转移。考虑到肿瘤侵袭性和缺乏BRCA1和BRCA2突变,我们开始用3周的卡铂/紫杉醇方案与Bevacizumab联合的全身化疗,这迅速改善了患者的症状并诱导了生物肿瘤反应。结论:本例报告了卵巢癌的同步乳房转移,并突出了这种罕见的实体,这很难诊断和治疗。来自原发性乳腺癌的差异诊断应被视为这两种肿瘤的治疗和预后是不同的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号